Nuclear receptors and female reproduction: A tale of 3 scientists, Jensen, Gustafsson, and O'Malley

Reproductive Sciences

Volumn 15, Issue 2, 2008, Pages 110-120

  Chaudhuri, Gautam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Estrogen receptor; Glucocorticoid receptor; Nuclear receptor; Progesterone receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; LIVER X RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR; VITAMIN D RECEPTOR; CELL RECEPTOR;

DNA BINDING; FEMALE GENITAL SYSTEM; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; ARTICLE; FEMALE; HISTORY; PHYSIOLOGY; REPRODUCTION;

FEMALE; HISTORY, 20TH CENTURY; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; REPRODUCTION;

EID: 40949115538     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108314516     Document Type: Review

References (115)

1. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT Nuclear receptor structure: implications for function. Annu Rev Physiol. 2007 ; 69: 201-220.
2. Jensen EV, Jacobson HI Fate of steroids in target tissues. In: Pincus G, Vollmer EP, eds. Biological Activities of Steroids in Relation to Cancer. Vol 1. New York, NY: Academic Press ; 1960:161-174.
3. Jensen EV, Jacobson HI Basic guides to the mechanism of estrogen action. Recent Prog Horm Res. 1962 ; 18: 387-414.
4. Gorski J., Toft D. Hormone receptors: studies on the interaction of estrogen with uterus. Recent Prog Horm Res. 1968 ; 24: 45-80.
5. Gorski J., Shyamala G., Toft D. Interrelationships of nuclear and cytoplasmic estrogen receptors. Curr Top Dev Biol. 1969 ; 4: 149-167.
6. Shyamala G., Gorski J. Estrogen receptors in the rat uterus: studies on the interaction of cytosol and nuclear binding sites. J Biol Chem. 1969 ; 244 (5). 1097-1103.
7. Jensen EV, Mohla S., Gorell TA, De Sombre ER The role of estrophilin in estrogen action. Vitam Horm. 1974 ; 32: 89-127.
8. De Sombre ER, Puca GA, Jensen EV Purification of an estrophilic protein from calf uterus. Proc Natl Acad Sci U S A. 1969 ; 64 (1). 148-154.
9. DeSombre ER, Greene GL, King WJ, Jensen EV Estrogen receptors, antibodies, and hormone dependent cancer. Prog Clin Biol Res. 1984 ; 42: 1-21.
10. Herman TS, Fimognari GM, Edelman IS Studies on renal aldosterone-binding proteins. J Biol Chem. 1968 ; 243 (14). 3849-3856.
11. Swaneck GE, Chu LL, Edelman IS Stereospecific binding of aldosterone to renal chromatin. J Biol Chem. 1970 ; 245 (20). 5382-5389.
12. Brecher PI, Wotiz HH Dissociation of estradiol from a uterine nuclear receptor. Endocrinology. 1969 ; 84 (4). 718-726.
13. Talalay P., Hurlock B., Williams-Ashman HG On a coenzymatic function of estradiol-17beta. Proc Natl Acad Sci U S A. 1958 ; 44 (9). 862-884.
14. Tomkins GM Regulation of gene expression in mammalian cells. Harvey Lect. 1974 ; 68: 37-65.
15. Tomkins GM, Garren LD, Howell RR, Peterkofsky B. The regulation of enzyme synthesis by steroid hormones: the role of translation. J Cell Physiol. 1965 ; 66 (2 suppl 1). 137-151.
16. Jacob F., Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 1961 ; 3: 318-356.
17. O'Malley BW In vitro hormonal induction of a specific protein (avidin) in chick oviduct. Biochemistry. 1967 ; 6 (8). 2546-255.
18. O'Malley BW, McGuire WL Studies on the mechanism of estrogen-mediated tissue differentiation: regulation of nuclear transcription and induction of new RNA species. Proc Natl Acad Sci U S A. 1968 ; 60 (4). 1527-1534.
19. Means AR, Comstock JP, Rosenfeld GC, O'Malley BW. Ovalbumin messenger RNA of chick oviduct: partial characterization, estrogen dependence and translation in vitro. Proc Natl Acad Sci U S A. 1972 ; 69: 1146-1150.
20. Kohler PO, Grimley PM, O' Malley BW Estrogen-induced cytodifferentiation of the ovalbumin-secreting glands of the chick oviduct. J Cell Biol. 1969 ; 40 (1). 8-27.
21. Rhoads RE, McKnight GS, Schimke RT Quantitative measurement of ovalbumin messenger ribonucleic acid activity Localization in polysomes, induction by estrogen, and effect of actinomycin. D J Biol Chem. 1973 ; 248 (6). 2031-2039.
22. Harris SE, Rosen JM, Means AR, O' Malley BW Use of a specific probe for ovalbumin messenger RNA to quantitate estrogen-induced gene transcripts. Biochemistry. 1975 ; 14 (10). 2072-2081.
23. Wrange O., Carlstedt-Duke J., Gustafsson JA Purification of the glucocorticoid receptor from rat liver cytosol. J Biol Chem. 1979 ; 254 (18). 9284-9290.
24. Carlstedt-Duke J., Okret S., Wrange O., and Gustafsson JA Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains. Proc Natl Acad Sci USA. 1982 ; 79 (14). 4260-4264.
25. Payvar F., Wrange O., Carlstedt-Duke J., Okret S., Gustafsson JA, Yamamoto KR Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci U S A. 1981 ; 78 (11). 6628-6632.
26. Payvar F., Firestone GL, Ross SR, et al. Multiple specific binding sites for purified glucocorticoid receptors on mammary tumor virus DNA. J Cell Biochem. 1982 ; 19 (3). 241-247.
27. Payvar F., DeFranco D., Firestone GL, et al. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell. 1983 ; 35 (2 pt 1). 381-392.
28. Yamamoto KR, Payvar F., Firestone GL, et al. Biological activity of cloned mammary tumor virus DNA fragments that bind pure glucocorticoid receptor protein in vitro. Cold Spring Harbor Symposia on Quantitative Biology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory ; 1983.
29. Miesfeld R., Okret S., Wikstrom AC, Wrange O., Gustafsson JA, Yamamoto KR Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature. 1984 ; 312 (5996). 779-781.
30. Weinberger C., Hollenberg SM, Ong ES, et al. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science. 1985 ; 228 (4700). 740-742.
31. Miesfeld, R., Rusconi S., Godowski PJ, et al. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell. 1986 ; 46 (3). 389-399.
32. Green S., Walter P., Greene G., et al. Cloning of the human oestrogen receptor cDNA. J Steroid Biochem. 1986 ; 24 (1). 77-83.
33. Conneely OM, Sullivan WP, Toft DO, et al. Molecular cloning of the chicken progesterone receptor. Science. 1986 ; 233 (4765). 767-770.
34. Jeltsch JM, Krozowski Z., Quirin-Stricker C., et al. Cloning of the chicken progesterone receptor. Proc Natl Acad Sci U S A. 1986 ; 83 (15). 5424-5428.
35. Hard T., Kellenbach E., Boelens R., et al. Solution structure of the glucocorticoid receptor DNA-binding domain. Science. 1990 ; 249 (4965). 157-160.
36. Brzozowski AM, Pike AC, Dauter Z., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 1997 ; 389 (6652). 753-758.
37. Ribeiro RCJ, Feng W., Wagner RL, et al. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. JBiol Chem. 2001 ; 276 (18). 14987-14995.
38. Pascal FE, Mitschier A., Rochel N., Ruff M., Chambon P., Moras D. Crystal structure of the human RXR-alpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 2000 ; 19 (11). 2592-2601.
39. Green S., Chambon P. A superfamily of potentially oncogenic hormone receptors. Nature. 1986 ; 324 (6098). 615-617.
40. Kuiper GG, Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson JA Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996 ; 93 (12). 5925-5930.
41. Sporn MB, Dunlop NM, Newton DL, Smith JM Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976 ; 35 (6). 1332-1338.
42. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol. 2005 ; 19 (6). 1418-1428.
43. P. Germain, Chambon P., Eichele G., Evans R., et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 2006 ; 58: 712-725.
44. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell. 1995 ; 83 (6). 859-869.
45. Petkovich M., Brand NJ, Krust A., Chambon P A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 1987 ; 330 (6147). 444-450.
46. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996 ; 10 (9). 940-954.
47. Giguere V., Ong ES, Segui P., Evans RM Identification of a receptor for the morphogen retinoic acid. Nature. 1987 ; 330 (6149). 624-629.
48. Li E., Sucov HM, Lee KF, Evans RM, Jaenisch R. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc Natl Acad Sci U S A. 1993 ; 90 (4). 1590-1594.
49. Lufkin T., Lohnes D., Mark M., et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci U S A. 1993 ; 90 (15). 7225-7229.
50. Grondona JM, Kastner P., Gansmuller A., Decimo D., Chambon P., Mark M. Retinal dysplasia and degeneration in RARbeta2/ RARgamma2 compound mutant mice. Development. 1996 ; 122 (7). 2173-2188.
51. Krezel W., Ghyselinck N., Samad TA, Dupe V., Kastner P., Borrelli E., Chambon P. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science. 1998 ; 279 (5352). 863-867
52. Lohnes D., Kastner P., Dierich A., Mark M., LeMeur M., Chambon P. Function of retinoic acid receptor gamma in the mouse. Cell. 1993 ; 73 (4). 643-658.
53. Ghyselinck NB, Dupe V., Dierich A., et al. Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int J Dev Biol. 1997 ; 41 (3). 425-447.
54. Chapellier B., Mark M., Messaddeq N., et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J. 2002 ; 21 (13). 3402-3413.
55. Germain P., Chambon P., Eichele G., et al. International union of pharmacology LX retinoic acid receptors. Pharmacol Rev. 2006 ; 58 (4). 712-725.
56. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 1990 ; 345 (6272). 224-229.
57. Hughes MR, Malloy PJ, Kieback DG, et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 1988 ; 242 (4886). 1702-1705.
58. Kato S., Yoshizazawa T., Kitanaka S., Murayama A., Takeyama K. Molecular genetics of vitamin D- dependent hereditary rickets. Horm Res. 2002 ; 57 (3-4). 73-78.
59. Li YC, Pirro AE, Amling M., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A. 1997 ; 94 (18). 9831-9835.
60. Yoshizawa T., Handa Y., Uematsu Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997 ; 16 (4). 391-396.
61. Van Cromphaut SJ, Dewerchin M., Hoenderop JG, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A. 2001 ; 98 (23). 13324-13329.
62. Zeitz U., Weber K., Soegiarto DW, Wolf E., Balling R., Erben RG Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003 ; 17 (3). 509-511.
63. Amling M., Priemel M., Holzmann T., et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology. 1999 ; 140 (11). 4982-4987.
64. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990 ; 347 (6294). 645-650.
65. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992 ; 68 (5). 879-887.
66. Banner CD, Gottlicher M., Widmark E., Sjovall J., Rafter JJ, Gustafsson JA A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma. J Lipid Res. 1993 ; 34 (9). 1583-1591.
67. Evans RM, Barish GD, Wang, YX PPARs and the complex journey to obesity. Nat Med. 2004 ; 10 (4). 355-361.
68. Devchand PR, Keller H., Peters JM, Vazquez M., Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 1996 ; 384 (6604). 39-43.
69. Serhan CN Inflammation signalling the fat controller. Nature. 1996 ; 384 (6604). 23-24.
70. Mandard S., Muller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci. 2004 ; 61 (4). 393-416.
71. Tontonoz P., Graves RA, Budavari AI, et al. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res. 1994 ; 22 (25). 5628-5634.
72. Tontonoz P., Hu E., Graves RA, Budavari AI, Spiegelman BM mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994 ; 8 (10). 1224-1234.
73. Lee SS, Pineau T., Drago J., et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995 ; 15 (6). 3012-3022.
74. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995 ; 270 (22). 12953-12956.
75. Kliewer SA, Umesono K., Noonan DJ, Heyman RA, Evans RM Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992 ; 358 (6389). 771-774.
76. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptorretinoid X receptor heterodimers. Proc Natl Acad Sci U S A. 1993 ; 90 (6). 2160-2164.
77. Tugwood JD, Issemann I., Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 1992 ; 11 (2). 433-439.
78. Feige JN, Gelman L., Tudor C., Engelborghs Y., Wahli W., Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J Biol Chem. 2005 ; 280 (18). 17880-17890.
79. Ordentlich P., Downes M., Evans RM Corepressors and nuclear hormone receptor function. Curr Top Microbiol Immunol. 2001 ; 254: 101-116.
80. Jepsen K., Rosenfeld MG Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci. 2002 ; 115 (pt 4). 689-698.
81. Privalsky ML The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol. 2004 ; 66: 315-360.
82. Dowell P., Ishmael JE, Avram D., Peterson VJ, Nevrivy DJ, Leid M. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J Biol Chem. 1999 ; 274 (22). 15901-15907.
83. StanleyTB, Leesnitzer LM, Montana VG, et al. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Biochemistry. 2003 ; 42 (31). 9278-9287.
84. Barish GD, Narkar VA, Evans RM PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest. 2006 ; 116 (3). 590-597.
85. Apfel R., Benbrook D., Lernhardt E., Ortiz MA, Salbert G., Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol. 1994 ; 14 (10). 7025-7035.
86. Willy PJ, Umesono K., Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995 ; 9 (9). 1033-1045.
87. Song C., Hiipakka RA, Kokontis JM, Liao S. Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones. Ann N Y Acad Sci. 1995 ; 761: 38-49.
88. Shinar DM, Endo N., Rutledge SJ, Vogel R., Rodan GA, Schmidt A. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene. 1994 ; 147 (2). 273-276.
89. Teboul M., Enmark E., Li Q., Wikstrom AC, Pelto-Huikko M., Gustafsson JA OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci USA. 1995 ; 92 (6). 2096-2100.
90. Seol W., Choi HS, Moore DD Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol. 1995 ; 9 (1). 72-85.
91. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996 ; 383 (6602). 728-731.
92. Peet DJ, Turley SD, Ma W., Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell. 1998 ; 93 (5). 693-704.
93. Alberti S., Schuster G., Parini P., et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbetadeficient mice. J Clin Invest. 2001 ; 107 (5). 565-573.
94. Forman BM, Goode E., Chen J., et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995 ; 81 (5). 687-693.
95. GiguereV., Yang N., Segui P., Evans RM Identification of a new class of steroid hormone receptors. Nature. 1988 ; 331 (6151). 91-94.
96. Eudy JD, Yao S., Weston MD, et al. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics. 1998 ; 50 (3). 382-384.
97. Spelsberg TC, Steggles AW, Chytil F., O' Malley BW Progesterone-binding components of chick oviduct exchange of progesterone-binding capacity from target to nontarget tissue chromatins. J Biol Chem. 1972 ; 247 (5). 1368-1374.
98. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2007 ; 28: 575-87.
99. Onate SA, Tsai SY, Tsai MJ, O' Malley BW Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 1995 ; 270 (5240). 1354-1357.
100. Gill G., Ptashne M. Negative effect of the transcriptional activator GAL4. Nature. 1988 ; 334 (6184). 721-724.
101. McDonnell DP, Vegeto E., O' Malley BW Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci U S A. 1992 ; 89 (22). 10563-10567.
102. Baniahmad A., Leng X., Burris TP, Tsai SY, Tsai MJ, O' Malley BW The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol. 1995 ; 15 (1). 76-86.
103. Kurokawa R., Soderstrom M., Horlein A., et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 1995 ; 377: 451-454.
104. Chen JD, Evans RM A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 1995 ; 377: 454-457.
105. Yoshinaga SK, Peterson CL, Herskowitz I., Yamamoto KR Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science. 1992 ; 258: 1598-1604.
106. Halachmi S., Martin ME, MacKay H., Abbrondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 1994 ; 3: 1455-1458.
107. Xu J., Qui Y., DeMayo FJ, Tsai SY, Tsai M-J., O' Malley BW Disruption of the steroid receptor coactivator 1 (SRC-1) gene in mice results in a syndrome of partial hormone resistance. Science. 1998 ; 279: 1922-1925.
108. Smith CL, Nawaz Z., O' Malley BW Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogens, 4-hydroxytamoxifen. Mol Endocrinol. 1997 ; 11: 657-666.
109. Kim JH, Li H., Stallcup MR CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol Cell. 2003 ; 6: 1537-1549.
110. Li X., Lonard DM, Jung SY, et al. The SRC-3/AIB1 coactivator is degraded in an ubiquitin- and ATP-independent manner by the REG-proteasome. Cell. 2006 ; 124: 381-392.
111. Kwok RP, Lundblad JR, Chrivia JC, et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 1994 ; 370: 223-226.
112. Wu Z., Puigserver P., Anderson U., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999 ; 98: 115-124.
113. Yu C., York B., Wang S., Feng Q., Xu J., O'Malley BW An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response. Mol Cell. 2007 ; 25: 765-778.
114. Anzick SL, Kononen J., Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997 ; 277: 965-968.
115. Lonard DM, O'Malley BW. Nuclear receptor coregulators: judges, juries and executioners of transcriptional regulation. Mol Cell. 2007 ; 27: 691-700.